HIPAA Alert: Potential Data Breach Learn More

Search
Close this search box.

NCT/Study#

N/A /

SALVAGETHERAPY-ALK/ALCL

Impact of Salvage Therapy on Outcomes in Patients with Relapsed/Refractory ALK+ Anaplastic Large Cell Lymphoma Prior to Autologous or Allogeneic Stem Cell Transplant

DISEASE GROUP:
Lymphoma
current phase:
N/A
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information: